CRDF
Cardiff Oncology Inc.
Company Overview
| Mkt Cap | $136.38M | Price | $2.29 |
| Volume | 359.73K | Change | -2.77% |
| P/E Ratio | -3.0 | Open | $2.35 |
| Revenue | $683.0K | Prev Close | $2.35 |
| Net Income | $-45.4M | 52W Range | $1.90 - $5.64 |
| Div Yield | N/A | Target | $10.50 |
| Overall | 49 | Value | 60 |
| Quality | 44 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyCardiff Oncology Inc. (CRDF) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $2.29 with a market capitalization of $136.38 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows CRDF with a volume of 360K shares. The stock opened down 0.00% from yesterday's close of $2.35. Current analyst estimates project earnings of $-0.81 per share for this year, with next year targeting $-0.86.
CRDF demonstrates weak technical indicators based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CRDF include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 359.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:27 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRDF | $2.29 | -2.8% | 359.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |